2019 Q1 Form 10-Q Financial Statement

#000156459019014051 Filed on April 30, 2019

View on sec.gov

Income Statement

Concept 2019 Q1 2018 Q1
Revenue $3.594B $3.789B
YoY Change -5.15% 11.38%
Cost Of Revenue $1.333B $1.342B
YoY Change -0.67% 6.68%
Gross Profit $2.261B $2.447B
YoY Change -7.6% 14.13%
Gross Profit Margin 62.91% 64.58%
Selling, General & Admin $414.0M $433.0M
YoY Change -4.39% -1.37%
% of Gross Profit 18.31% 17.7%
Research & Development $389.0M $385.0M
YoY Change 1.04% 4.34%
% of Gross Profit 17.2% 15.73%
Depreciation & Amortization $166.0M $229.0M
YoY Change -27.51% -0.43%
% of Gross Profit 7.34% 9.36%
Operating Expenses $803.0M $818.0M
YoY Change -1.83% -7.88%
Operating Profit $1.379B $1.548B
YoY Change -10.92% 23.64%
Interest Expense -$38.00M -$23.00M
YoY Change 65.22% 27.78%
% of Operating Profit -2.76% -1.49%
Other Income/Expense, Net $36.00M $28.00M
YoY Change 28.57% 33.33%
Pretax Income $1.377B $1.553B
YoY Change -11.33% 23.75%
Income Tax $160.0M $187.0M
% Of Pretax Income 11.62% 12.04%
Net Earnings $1.217B $1.366B
YoY Change -10.91% 37.01%
Net Earnings / Revenue 33.86% 36.05%
Basic Earnings Per Share $1.29 $1.38
Diluted Earnings Per Share $1.26 $1.35
COMMON SHARES
Basic Shares Outstanding 939.0M shares 983.0M
Diluted Shares Outstanding 956.0M shares 1.005B

Balance Sheet

Concept 2019 Q1 2018 Q1
SHORT-TERM ASSETS
Cash & Short-Term Investments $4.086B $4.079B
YoY Change 0.17% 33.78%
Cash & Equivalents $3.720B $1.717B
Short-Term Investments $366.0M $2.362B
Other Short-Term Assets $294.0M $1.025B
YoY Change -71.32% 26.39%
Inventory $2.131B $2.032B
Prepaid Expenses
Receivables $1.440B $1.454B
Other Receivables $0.00 $0.00
Total Short-Term Assets $7.951B $8.590B
YoY Change -7.44% 22.02%
LONG-TERM ASSETS
Property, Plant & Equipment $3.664B $2.736B
YoY Change 33.92% 9.4%
Goodwill
YoY Change
Intangibles
YoY Change
Long-Term Investments $308.0M $295.0M
YoY Change 4.41% 11.74%
Other Assets $511.0M $556.0M
YoY Change -8.09% 8.81%
Total Long-Term Assets $9.492B $8.917B
YoY Change 6.45% -0.23%
TOTAL ASSETS
Total Short-Term Assets $7.951B $8.590B
Total Long-Term Assets $9.492B $8.917B
Total Assets $17.44B $17.51B
YoY Change -0.37% 9.57%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable $477.0M $488.0M
YoY Change -2.25% 13.75%
Accrued Expenses $819.0M $739.0M
YoY Change 10.83% 2.92%
Deferred Revenue
YoY Change
Short-Term Debt $0.00 $0.00
YoY Change
Long-Term Debt Due $750.0M $500.0M
YoY Change 50.0% 32.28%
Total Short-Term Liabilities $2.159B $1.860B
YoY Change 16.08% 16.1%
LONG-TERM LIABILITIES
Long-Term Debt $5.057B $3.578B
YoY Change 41.34% 20.07%
Other Long-Term Liabilities $1.545B $1.374B
YoY Change 12.45% 90.57%
Total Long-Term Liabilities $1.545B $4.952B
YoY Change -68.8% 33.8%
TOTAL LIABILITIES
Total Short-Term Liabilities $2.159B $1.860B
Total Long-Term Liabilities $1.545B $4.952B
Total Liabilities $8.924B $6.865B
YoY Change 29.99% 28.58%
SHAREHOLDERS EQUITY
Retained Earnings
YoY Change
Common Stock
YoY Change
Preferred Stock
YoY Change
Treasury Stock (at cost)
YoY Change
Treasury Stock Shares
Shareholders Equity $8.519B $10.64B
YoY Change
Total Liabilities & Shareholders Equity $17.44B $17.51B
YoY Change -0.37% 9.57%

Cashflow Statement

Concept 2019 Q1 2018 Q1
OPERATING ACTIVITIES
Net Income $1.217B $1.366B
YoY Change -10.91% 37.01%
Depreciation, Depletion And Amortization $166.0M $229.0M
YoY Change -27.51% -0.43%
Cash From Operating Activities $1.107B $1.112B
YoY Change -0.45% 39.87%
INVESTING ACTIVITIES
Capital Expenditures $251.0M -$189.0M
YoY Change -232.8% -248.82%
Acquisitions
YoY Change
Other Investing Activities $13.00M $455.0M
YoY Change -97.14% 4955.56%
Cash From Investing Activities $1.173B $266.0M
YoY Change 340.98% -0.37%
FINANCING ACTIVITIES
Cash Dividend Paid $724.0M $611.0M
YoY Change 18.49%
Common Stock Issuance & Retirement, Net $1.152B $873.0M
YoY Change 31.96%
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities -$998.0M -1.317B
YoY Change -24.22% 15.22%
NET CHANGE
Cash From Operating Activities $1.107B 1.112B
Cash From Investing Activities $1.173B 266.0M
Cash From Financing Activities -$998.0M -1.317B
Net Change In Cash $1.282B 61.00M
YoY Change 2001.64% -175.31%
FREE CASH FLOW
Cash From Operating Activities $1.107B $1.112B
Capital Expenditures $251.0M -$189.0M
Free Cash Flow $856.0M $1.301B
YoY Change -34.2% 94.76%

Facts In Submission

Frame Concept Type Concept / XBRL Key Value Unit
CY2019Q1 dei Entity Small Business
EntitySmallBusiness
false
CY2019Q1 dei Entity Emerging Growth Company
EntityEmergingGrowthCompany
false
CY2019Q2 dei Entity Common Stock Shares Outstanding
EntityCommonStockSharesOutstanding
938206171
CY2019Q1 dei Document Type
DocumentType
10-Q
CY2019Q1 dei Amendment Flag
AmendmentFlag
false
CY2019Q1 dei Document Period End Date
DocumentPeriodEndDate
2019-03-31
CY2019Q1 us-gaap Gross Profit
GrossProfit
2261000000
CY2018Q1 us-gaap Gross Profit
GrossProfit
2447000000
CY2019Q1 us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
389000000
CY2018Q1 us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
385000000
CY2019Q1 us-gaap Selling General And Administrative Expense
SellingGeneralAndAdministrativeExpense
414000000
CY2018Q1 us-gaap Selling General And Administrative Expense
SellingGeneralAndAdministrativeExpense
433000000
CY2019Q1 us-gaap Business Combination Acquisition Related Costs
BusinessCombinationAcquisitionRelatedCosts
79000000
CY2018Q1 us-gaap Business Combination Acquisition Related Costs
BusinessCombinationAcquisitionRelatedCosts
80000000
CY2019Q1 txn Restructuring Charges Other
RestructuringChargesOther
0
CY2018Q1 txn Restructuring Charges Other
RestructuringChargesOther
1000000
CY2019Q1 us-gaap Operating Income Loss
OperatingIncomeLoss
1379000000
CY2018Q1 us-gaap Operating Income Loss
OperatingIncomeLoss
1548000000
CY2019Q1 us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
36000000
CY2018Q1 us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
28000000
CY2019Q1 us-gaap Interest And Debt Expense
InterestAndDebtExpense
38000000
CY2018Q1 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
187000000
CY2018Q1 us-gaap Interest And Debt Expense
InterestAndDebtExpense
23000000
CY2019Q1 us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
1377000000
CY2019Q1 us-gaap Net Income Loss
NetIncomeLoss
1217000000
CY2018Q1 us-gaap Net Income Loss
NetIncomeLoss
1366000000
CY2018Q1 us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
1553000000
CY2019Q1 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
160000000
CY2019Q1 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
1.29
CY2018Q1 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
1.38
CY2019Q1 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
1.26
CY2018Q1 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
1.35
CY2019Q1 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
939000000
CY2018Q1 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
983000000
CY2019Q1 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
956000000
CY2018Q1 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
1005000000
CY2019Q1 us-gaap Other Liabilities Noncurrent
OtherLiabilitiesNoncurrent
1545000000
CY2018Q4 us-gaap Other Liabilities Noncurrent
OtherLiabilitiesNoncurrent
1190000000
CY2019Q1 us-gaap Effective Income Tax Rate Reconciliation At Federal Statutory Income Tax Rate
EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate
0.21
CY2018Q4 us-gaap Debt Instrument Unamortized Discount Premium And Debt Issuance Costs Net
DebtInstrumentUnamortizedDiscountPremiumAndDebtIssuanceCostsNet
32000000
CY2019Q1 us-gaap Long Term Debt
LongTermDebt
5807000000
CY2018Q4 us-gaap Long Term Debt
LongTermDebt
5068000000
CY2019Q1 us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
1107000000
CY2018Q1 us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
1112000000
CY2019Q1 txn Lessee Operating Lease Liability Imputed Lease Interest Expense
LesseeOperatingLeaseLiabilityImputedLeaseInterestExpense
58000000
CY2019Q1 us-gaap Operating Lease Liability
OperatingLeaseLiability
346000000
CY2019Q1 us-gaap Goodwill Impairment Loss
GoodwillImpairmentLoss
0
CY2019Q1 us-gaap Payments For Repurchase Of Common Stock
PaymentsForRepurchaseOfCommonStock
1152000000
CY2018Q1 us-gaap Payments For Repurchase Of Common Stock
PaymentsForRepurchaseOfCommonStock
873000000
CY2019Q1 us-gaap Proceeds From Issuance Or Sale Of Equity
ProceedsFromIssuanceOrSaleOfEquity
151000000
CY2018Q1 us-gaap Proceeds From Issuance Or Sale Of Equity
ProceedsFromIssuanceOrSaleOfEquity
178000000
CY2019Q1 us-gaap Proceeds From Payments For Other Financing Activities
ProceedsFromPaymentsForOtherFinancingActivities
-16000000
CY2018Q1 us-gaap Proceeds From Payments For Other Financing Activities
ProceedsFromPaymentsForOtherFinancingActivities
-11000000
CY2019Q1 us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
-998000000
CY2018Q1 us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
-1317000000
CY2019Q1 us-gaap Cash And Cash Equivalents Period Increase Decrease
CashAndCashEquivalentsPeriodIncreaseDecrease
1282000000
CY2018Q1 us-gaap Cash And Cash Equivalents Period Increase Decrease
CashAndCashEquivalentsPeriodIncreaseDecrease
61000000
CY2017Q4 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
1656000000
CY2018Q1 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
1717000000
CY2019Q1 us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
1173000000
CY2018Q1 us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
266000000
CY2019Q1 us-gaap Proceeds From Issuance Of Long Term Debt
ProceedsFromIssuanceOfLongTermDebt
743000000
CY2018Q1 us-gaap Proceeds From Issuance Of Long Term Debt
ProceedsFromIssuanceOfLongTermDebt
0
CY2019Q1 us-gaap Payments Of Dividends
PaymentsOfDividends
724000000
CY2018Q1 us-gaap Payments Of Dividends
PaymentsOfDividends
611000000
CY2018Q1 us-gaap Goodwill Impairment Loss
GoodwillImpairmentLoss
0
CY2019Q1 us-gaap Finite Lived Intangible Assets Gross
FiniteLivedIntangibleAssetsGross
2935000000
CY2019Q1 us-gaap Loss Contingency Disclosures
LossContingencyDisclosures
<p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">10. <font style="text-decoration:underline;">Contingencies</font></p> <p style="margin-top:12pt;margin-bottom:0pt;text-indent:0%;font-style:italic;font-family:Times New Roman;font-size:10pt;font-weight:normal;text-transform:none;font-variant: normal;">Indemnification guarantees</p> <p style="margin-bottom:12pt;margin-top:12pt;text-indent:0%;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">We routinely sell products with an intellectual property indemnification included in the terms of sale. Historically, we have had only minimal, infrequent losses associated with these indemnities. Consequently, we cannot reasonably estimate any future liabilities that may result.</p> <p style="margin-top:12pt;margin-bottom:0pt;text-indent:0%;font-style:italic;font-family:Times New Roman;font-size:10pt;font-weight:normal;text-transform:none;font-variant: normal;">Warranty costs/product liabilities</p> <p style="margin-bottom:12pt;margin-top:12pt;text-indent:0%;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">We accrue for known product-related claims if a loss is probable and can be reasonably estimated. During the periods presented, there have been no material accruals or payments regarding product warranty or product liability. Historically, we have experienced a low rate of payments on product claims. Although we cannot predict the&#160;likelihood or amount of any future claims, we do not believe they will have a material adverse effect on our financial condition, results of operations or liquidity. Our stated warranties for semiconductor products obligate us to repair, replace or credit the purchase price of a covered product back to the buyer. Product claim consideration may exceed the price of our products. </p> <p style="margin-top:12pt;margin-bottom:0pt;text-indent:0%;font-style:italic;font-family:Times New Roman;font-size:10pt;font-weight:normal;text-transform:none;font-variant: normal;">General</p> <p style="margin-top:12pt;margin-bottom:0pt;text-indent:0%;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">We are subject to various legal and administrative proceedings. Although it is not possible to predict the outcome of these matters, we believe that the results of these proceedings will not have a material adverse effect on our financial condition, results of operations or liquidity. </p> <p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-weight:bold;;font-size:9pt;">&nbsp;</p>
CY2019Q1 us-gaap Finite Lived Intangible Assets Accumulated Amortization
FiniteLivedIntangibleAssetsAccumulatedAmortization
2386000000
CY2019Q1 us-gaap Guarantees Indemnifications And Warranties Policies
GuaranteesIndemnificationsAndWarrantiesPolicies
<p style="margin-top:12pt;margin-bottom:0pt;text-indent:0%;font-style:italic;font-family:Times New Roman;font-size:10pt;font-weight:normal;text-transform:none;font-variant: normal;">Indemnification guarantees</p> <p style="margin-bottom:12pt;margin-top:12pt;text-indent:0%;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">We routinely sell products with an intellectual property indemnification included in the terms of sale. Historically, we have had only minimal, infrequent losses associated with these indemnities. Consequently, we cannot reasonably estimate any future liabilities that may result.</p> <p style="margin-top:12pt;margin-bottom:0pt;text-indent:0%;font-style:italic;font-family:Times New Roman;font-size:10pt;font-weight:normal;text-transform:none;font-variant: normal;">Warranty costs/product liabilities</p> <p style="margin-bottom:12pt;margin-top:12pt;text-indent:0%;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">We accrue for known product-related claims if a loss is probable and can be reasonably estimated. During the periods presented, there have been no material accruals or payments regarding product warranty or product liability. Historically, we have experienced a low rate of payments on product claims. Although we cannot predict the&#160;likelihood or amount of any future claims, we do not believe they will have a material adverse effect on our financial condition, results of operations or liquidity. Our stated warranties for semiconductor products obligate us to repair, replace or credit the purchase price of a covered product back to the buyer. Product claim consideration may exceed the price of our products. </p>
CY2018Q4 us-gaap Restructuring Reserve
RestructuringReserve
28000000
CY2018Q4 us-gaap Finite Lived Intangible Assets Gross
FiniteLivedIntangibleAssetsGross
2935000000
CY2019Q1 us-gaap Restructuring Reserve
RestructuringReserve
16000000
CY2019Q1 us-gaap Undistributed Earnings Loss Allocated To Participating Securities Basic
UndistributedEarningsLossAllocatedToParticipatingSecuritiesBasic
8000000
CY2018Q1 us-gaap Undistributed Earnings Loss Allocated To Participating Securities Basic
UndistributedEarningsLossAllocatedToParticipatingSecuritiesBasic
11000000
CY2019Q1 us-gaap Net Income Loss Available To Common Stockholders Basic
NetIncomeLossAvailableToCommonStockholdersBasic
1209000000
CY2018Q1 us-gaap Net Income Loss Available To Common Stockholders Basic
NetIncomeLossAvailableToCommonStockholdersBasic
1355000000
CY2019Q1 us-gaap Weighted Average Number Diluted Shares Outstanding Adjustment
WeightedAverageNumberDilutedSharesOutstandingAdjustment
17000000
CY2018Q1 us-gaap Weighted Average Number Diluted Shares Outstanding Adjustment
WeightedAverageNumberDilutedSharesOutstandingAdjustment
22000000
CY2019Q1 us-gaap Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount
AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
9000000
CY2018Q1 us-gaap Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount
AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
5000000
CY2019Q1 txn Estimated Annual Effective Income Tax Rate Continuing Operations
EstimatedAnnualEffectiveIncomeTaxRateContinuingOperations
0.16
CY2019Q1 txn Income Tax Reconciliation Income Tax Expense Benefit At Estimated Annual Effective Income Tax Rate
IncomeTaxReconciliationIncomeTaxExpenseBenefitAtEstimatedAnnualEffectiveIncomeTaxRate
220000000
CY2018Q1 txn Income Tax Reconciliation Income Tax Expense Benefit At Estimated Annual Effective Income Tax Rate
IncomeTaxReconciliationIncomeTaxExpenseBenefitAtEstimatedAnnualEffectiveIncomeTaxRate
316000000
CY2019Q1 txn Income Tax Reconciliation Discrete Tax Items
IncomeTaxReconciliationDiscreteTaxItems
60000000
CY2018Q1 txn Income Tax Reconciliation Discrete Tax Items
IncomeTaxReconciliationDiscreteTaxItems
129000000
CY2019Q1 us-gaap Effective Income Tax Rate Continuing Operations
EffectiveIncomeTaxRateContinuingOperations
0.12
CY2018Q1 us-gaap Effective Income Tax Rate Continuing Operations
EffectiveIncomeTaxRateContinuingOperations
0.12
CY2019Q1 us-gaap Cash And Cash Equivalents Fair Value Disclosure
CashAndCashEquivalentsFairValueDisclosure
3720000000
CY2018Q4 us-gaap Cash And Cash Equivalents Fair Value Disclosure
CashAndCashEquivalentsFairValueDisclosure
2438000000
CY2019Q1 us-gaap Other Than Temporary Impairment Loss Debt Securities Available For Sale Recognized In Earnings
OtherThanTemporaryImpairmentLossDebtSecuritiesAvailableForSaleRecognizedInEarnings
0
CY2018Q1 us-gaap Other Than Temporary Impairment Loss Debt Securities Available For Sale Recognized In Earnings
OtherThanTemporaryImpairmentLossDebtSecuritiesAvailableForSaleRecognizedInEarnings
0
CY2019Q1 us-gaap Available For Sale Securities Debt Maturities Within One Year Fair Value
AvailableForSaleSecuritiesDebtMaturitiesWithinOneYearFairValue
3644000000
CY2019Q1 txn Available For Sale Securities Debt Maturities After One Through Two Years Fair Value
AvailableForSaleSecuritiesDebtMaturitiesAfterOneThroughTwoYearsFairValue
157000000
CY2019Q1 us-gaap Lessee Operating Lease Liability Payments Due
LesseeOperatingLeaseLiabilityPaymentsDue
404000000
CY2018Q4 us-gaap Finite Lived Intangible Assets Accumulated Amortization
FiniteLivedIntangibleAssetsAccumulatedAmortization
2307000000
CY2019Q1 us-gaap Commercial Paper
CommercialPaper
0
CY2019Q1 us-gaap Debt Instrument Carrying Amount
DebtInstrumentCarryingAmount
5850000000
CY2018Q4 us-gaap Debt Instrument Carrying Amount
DebtInstrumentCarryingAmount
5100000000
CY2019Q1 us-gaap Debt Instrument Unamortized Discount Premium And Debt Issuance Costs Net
DebtInstrumentUnamortizedDiscountPremiumAndDebtIssuanceCostsNet
43000000
CY2019Q1 us-gaap Common Stock Dividends Per Share Declared
CommonStockDividendsPerShareDeclared
0.77
CY2018Q1 us-gaap Common Stock Dividends Per Share Declared
CommonStockDividendsPerShareDeclared
0.62
CY2019Q1 us-gaap Operating Lease Right Of Use Asset
OperatingLeaseRightOfUseAsset
346000000
CY2019Q1 us-gaap Operating Lease Liability Current
OperatingLeaseLiabilityCurrent
70000000
CY2019Q1 us-gaap Operating Lease Liability Noncurrent
OperatingLeaseLiabilityNoncurrent
276000000
CY2019Q1 us-gaap Lease Cost
LeaseCost
18000000
CY2019Q1 us-gaap Variable Lease Cost
VariableLeaseCost
13000000
CY2019Q1 us-gaap Operating Lease Payments
OperatingLeasePayments
16000000
CY2019Q1 us-gaap Right Of Use Asset Obtained In Exchange For Operating Lease Liability
RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability
129000000
CY2019Q1 us-gaap Operating Lease Weighted Average Remaining Lease Term1
OperatingLeaseWeightedAverageRemainingLeaseTerm1
P8Y9M18D
CY2019Q1 us-gaap Operating Lease Weighted Average Discount Rate Percent
OperatingLeaseWeightedAverageDiscountRatePercent
0.0343
CY2019Q1 us-gaap Lessee Operating Lease Liability Payments Remainder Of Fiscal Year
LesseeOperatingLeaseLiabilityPaymentsRemainderOfFiscalYear
54000000
CY2019Q1 us-gaap Lessee Operating Lease Liability Payments Due Year Two
LesseeOperatingLeaseLiabilityPaymentsDueYearTwo
65000000
CY2019Q1 us-gaap Lessee Operating Lease Liability Payments Due Year Three
LesseeOperatingLeaseLiabilityPaymentsDueYearThree
53000000
CY2019Q1 us-gaap Lessee Operating Lease Liability Payments Due Year Four
LesseeOperatingLeaseLiabilityPaymentsDueYearFour
45000000
CY2019Q1 us-gaap Lessee Operating Lease Liability Payments Due Year Five
LesseeOperatingLeaseLiabilityPaymentsDueYearFive
33000000
CY2019Q1 us-gaap Lessee Operating Lease Liability Payments Due After Year Five
LesseeOperatingLeaseLiabilityPaymentsDueAfterYearFive
154000000
CY2019Q1 us-gaap Stock Issued During Period Shares Share Based Compensation
StockIssuedDuringPeriodSharesShareBasedCompensation
5712018

Files In Submission

Name View Source Status
0001564590-19-014051-index-headers.html Edgar Link pending
0001564590-19-014051-index.html Edgar Link pending
0001564590-19-014051.txt Edgar Link pending
0001564590-19-014051-xbrl.zip Edgar Link pending
FilingSummary.xml Edgar Link unprocessable
Financial_Report.xlsx Edgar Link pending
R1.htm Edgar Link pending
R10.htm Edgar Link pending
R11.htm Edgar Link pending
R12.htm Edgar Link pending
R13.htm Edgar Link pending
R14.htm Edgar Link pending
R15.htm Edgar Link pending
R16.htm Edgar Link pending
R17.htm Edgar Link pending
R18.htm Edgar Link pending
R19.htm Edgar Link pending
R2.htm Edgar Link pending
R20.htm Edgar Link pending
R21.htm Edgar Link pending
R22.htm Edgar Link pending
R23.htm Edgar Link pending
R24.htm Edgar Link pending
R25.htm Edgar Link pending
R26.htm Edgar Link pending
R27.htm Edgar Link pending
R28.htm Edgar Link pending
R29.htm Edgar Link pending
R3.htm Edgar Link pending
R30.htm Edgar Link pending
R31.htm Edgar Link pending
R32.htm Edgar Link pending
R33.htm Edgar Link pending
R34.htm Edgar Link pending
R35.htm Edgar Link pending
R36.htm Edgar Link pending
R37.htm Edgar Link pending
R38.htm Edgar Link pending
R39.htm Edgar Link pending
R4.htm Edgar Link pending
R40.htm Edgar Link pending
R41.htm Edgar Link pending
R42.htm Edgar Link pending
R43.htm Edgar Link pending
R44.htm Edgar Link pending
R45.htm Edgar Link pending
R46.htm Edgar Link pending
R47.htm Edgar Link pending
R48.htm Edgar Link pending
R49.htm Edgar Link pending
R5.htm Edgar Link pending
R50.htm Edgar Link pending
R51.htm Edgar Link pending
R52.htm Edgar Link pending
R53.htm Edgar Link pending
R54.htm Edgar Link pending
R6.htm Edgar Link pending
R7.htm Edgar Link pending
R8.htm Edgar Link pending
R9.htm Edgar Link pending
report.css Edgar Link pending
Show.js Edgar Link pending
txn-10q_20190331.htm Edgar Link pending
txn-20190331.xml Edgar Link completed
txn-20190331.xsd Edgar Link pending
txn-20190331_cal.xml Edgar Link unprocessable
txn-20190331_def.xml Edgar Link unprocessable
txn-20190331_lab.xml Edgar Link unprocessable
txn-20190331_pre.xml Edgar Link unprocessable
txn-ex31a_9.htm Edgar Link pending
txn-ex31b_7.htm Edgar Link pending
txn-ex32a_6.htm Edgar Link pending
txn-ex32b_8.htm Edgar Link pending